Audit of Antibiotic Prescription in Suspected Neonatal Sepsis at an Indian Tertiary Care Hospital
Abstract
Neonatal sepsis is one of the most typical causes of neonatal morbidity and mortality in the developing world. Rational use of antibacterial is a priority to prevent the emergence of resistance and to reduce the burden of treatment failure. This study was a prospective, cross-sectional study that collected data from 148 records of clinically suspected neonatal sepsis in a tertiary care hospital between January to December 2017. The isolated organisms, prescribing patterns, approval status, and list of antibacterial in WHO Essential Medicines List/NLEM were analyzed and presented as percentages, mean and standard deviations using appropriate tables and graphs. Of the 430 antibacterials examined, single-drug formulations were most commonly prescribed [400(93.02%)]; 298(69.30%) and 427(99.30%) were approved by DCGI and USFDA, respectively; 275(63.95%) antibacterials were included in both WHO and NLEM. The most common isolated organisms were gram-negative (64.1%). The most common class of antibacterial prescribed was beta-lactams (ATC class: J01D and J01C) [251(58.37%)] followed by aminoglycosides (ATC class: J01G) [124(28.84%)] irrespective of culture and sensitivity and their generic names prescribed almost 50% (216) of drugs. Regarding outcome, 87.16% of cases recovered well. In conclusion, the rationality of antibacterial drug usage in suspected cases of neonatal sepsis was followed the majority of times, leading to better patient care and outcome.
Keywords
Full Text:
PDFReferences
Gandhi S, Ranjan KP, Ranjan N, Sapre N and Masani M. Incidence of neonatal sepsis in tertiary care hospital: an overview. Int J Med Sci Public Health. 2013; 2: 548-52.
Klein OJ. Bacteriology of neonatal sepsis. Ped Inf Dis J. 1990; 9(10): 777-8.
Bang AJ, Bang RA and Baitale B. Burden of morbidities and unmet need for Healthcare in rural Indian neonate. Ind Pediatr. 2001; 38: 952-65.
Kaftan H and Kinney JS. Early onset neonatal bacterial infections. Semin Perinatol. 1998; 22: 15-24.
Baltimore SR, Huie MS, Meek IJ, Schuchat A and O’Brien LK. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatr. 2001; 108(5): 1094-8.
Stoll JB, Hansen N, Fanaroff AA, Wright LL, Carlo WA and Ehrenkranz RA. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. The N Engl J Med. 2002; 347(4): 240-7.
WHO. The world Health Report 2002: Reducing the risk and promoting healthy life. Geneva. World Health Organization 2002.
Begg SA, Cransweek NE and Reed MD. Improving drug use for children of the developing world. Arch Dis Child. 2005; 90: 1091-3.
Sachdeva PD and Patel BG. Drug Utilization Studies- Scope and future perspectives. Int J Pharm Biol Res. 2010; 1: 11-7.
Rasul HC, Hassan AM and Habibullah M. Neonatal Sepsis and use of antibiotic in a Tertiary care Hospital. Pak J Med Sci. 2007; 23(1): 78-81.
List of Drugs Approved for Marketing in India. Available at: http://cdsco.nic.in/listofdrugapprovedmain.html. [Accessed June 16, 2018].
Drugs@FDA:FDA Approved Drug Products. Available at: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm. [Accessed June 16, 2018].
WHO Model List of Essential Medicines for Children. World Health Organization. 2015: 1–38. Available at: http://www.who.int/medicines/publications/essentialmedicines/en/index.html. [Accessed June 19, 2018].
National List of Essential Medicines of India. 2011: 1-123. Available at: http://cdsco.nic.in/NationalListofEssentialMedicine- finalcopy.pdf. [Accessed June 19, 2018].
Aggarwal R, Sarkar N, Deorari AK and Paul VK. Sepsis in the Newborn. AIIMS protocols in Neonatology. CBS Publishers, Delhi, 2014: 1-19.
Sivanandan S, Soraisham SA and Swarnam K. Choice and Duration of Antimicrobial Therapy for Neonatal Sepsis and Meningitis. Int J Pediatr. 2011: 712150.
Tripati KD. Essentials of medical Pharmacology, 7th ed, Jaypee, New Delhi, 2013: 743-9.
DOI: https://doi.org/10.15416/pcpr.v7i1.35588
Refbacks
- There are currently no refbacks.
